🇺🇸 FDA
Patent

US 6316197

Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes

expired A61PA61P43/00

Quick answer

US patent 6316197 (Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P43/00